Plant Bio Technologies: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Plant Bio Technologies
Largest movements
- Intangible fixed assets +€233,362
new in 2025: €233,362
- Receivables within one year +€17,881
up €17,881 (+2.3%), from €784,134 to €802,015
of which Other amounts receivable: +€51,363
- Trade debts +€252,756
up €252,756 (+1,292%), from €19,561 to €272,317
- Profit (loss) carried forward -€29,896
down €29,896 (-70.0%), from -€42,724 to -€72,620
- Other debts +€22,219
up €22,219 (+4.4%), from €505,674 to €527,894
- Depreciation +€25,929
up €25,929 (+1,926%), from €1,347 to €27,276
- Staff costs +€5,647
up €5,647 (+221%), from €2,553 to €8,201
- Financial charges +€3,048
up €3,048 (+511%), from €596 to €3,644
- Other operating charges -€1,913
down €1,913 (-74.3%), from €2,573 to €661
- Gross operating margin +€1,025
up €1,025 (+7.0%), from -€14,601 to -€13,576
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €795,355 | €1,043,430 | +€248,075 | +31.2% |
| Fixed assets | 21/28 | €3,232 | €235,247 | +€232,016 | +7,179% |
| Intangible fixed assets | 21 | - | €233,362 | +€233,362 | |
| Tangible fixed assets | 22/27 | €3,232 | €1,885 | -€1,347 | -41.7% |
| Plant, machinery and equipment | 23 | €3,232 | €1,885 | -€1,347 | -41.7% |
| Current assets | 29/58 | €792,123 | €808,182 | +€16,059 | +2.0% |
| Amounts receivable within one year | 40/41 | €784,134 | €802,015 | +€17,881 | +2.3% |
| Trade receivables | 40 | €368,971 | €335,490 | -€33,482 | -9.1% |
| Other amounts receivable | 41 | €415,163 | €466,525 | +€51,363 | +12.4% |
| Cash at bank and in hand | 54/58 | €7,572 | €5,921 | -€1,651 | -21.8% |
| Deferred charges and accrued income | 490/1 | €417 | €246 | -€171 | -41.0% |
| Total equity and liabilities | 10/49 | €795,355 | €1,043,430 | +€248,075 | +31.2% |
| Equity | 10/15 | €269,776 | €239,880 | -€29,896 | -11.1% |
| Contributions | 10/11 | €312,500 | €312,500 | = | 0.0% |
| Capital | 10 | €312,500 | €312,500 | = | 0.0% |
| Issued capital | 100 | €312,500 | €312,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€42,724 | -€72,620 | -€29,896 | -70.0% |
| Amounts payable | 17/49 | €525,579 | €803,550 | +€277,971 | +52.9% |
| Amounts payable within one year | 42/48 | €525,579 | €803,550 | +€277,971 | +52.9% |
| Trade debts | 44 | €19,561 | €272,317 | +€252,756 | +1,292% |
| Suppliers | 440/4 | €19,561 | €272,317 | +€252,756 | +1,292% |
| Taxes, remuneration and social security | 45 | €344 | €3,339 | +€2,995 | +871% |
| Taxes | 450/3 | €344 | €2,706 | +€2,362 | +687% |
| Remuneration and social security | 454/9 | - | €633 | +€633 | |
| Other amounts payable | 47/48 | €505,674 | €527,894 | +€22,219 | +4.4% |
| Remuneration, social security and pensions | 62 | €2,553 | €8,201 | +€5,647 | +221% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,347 | €27,276 | +€25,929 | +1,926% |
| Other operating charges | 640/8 | €2,573 | €661 | -€1,913 | -74.3% |
| Gross operating margin | 9900 | -€14,601 | -€13,576 | +€1,025 | +7.0% |
| Operating profit (loss) | 9901 | -€21,074 | -€49,713 | -€28,639 | -136% |
| Financial income | 75/76B | €24,187 | €23,701 | -€487 | -2.0% |
| Recurring financial income | 75 | €24,187 | €23,701 | -€487 | -2.0% |
| Financial charges | 65/66B | €596 | €3,644 | +€3,048 | +511% |
| Recurring financial charges | 65 | €596 | €3,644 | +€3,048 | +511% |
| Profit (loss) for the period before taxes | 9903 | €2,517 | -€29,657 | -€32,173 | |
| Income taxes | 67/77 | €413 | €240 | -€173 | -42.0% |
| Profit (loss) for the period | 9904 | €2,104 | -€29,896 | -€32,000 | |
| Profit (loss) for the period to be appropriated | 9905 | €2,104 | -€29,896 | -€32,000 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.